Shreeram Aradhye

Shreeram Aradhye

President, Development and Chief Medical Officer | Basel, Basel-Stadt, Switzerland

*50 free lookup(s) per month.

No credit card required.

Shreeram Aradhye’s Emails

Shreeram Aradhye’s Phone Numbers

Social Media

Shreeram Aradhye’s Location

Shreeram Aradhye’s Expertise

Shreeram Aradhye’s Current Industry

Shreeram Aradhye’s Prior Industry

Not the Shreeram Aradhye you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Novartis

President, Development and Chief Medical Officer

2022-05-01 — Present

Dicerna Pharmaceuticals, Inc.

Chief Medical Officer

2020-09-01 — 2022-03-01

Axcella

Board Member

2020-09-01 — 2022-05-01

Valo Health

Board Member

2020-03-01 — 2022-05-01

Axcella

Chief Development Officer

2019-05-01 — 2020-08-01

Novartis

Global Head, Medical Affairs & Chief Medical Officer, Novartis Pharmaceuticals

2017-02-01 — 2019-04-01

Novartis

Global Head, Development Franchise, Neuroscience

2013-11-01 — 2017-02-01

Novartis

Executive Global Program Head, Multiple Sclerosis

2012-08-01 — 2013-10-01

Novartis

Head, Global Development India

2011-06-01 — 2012-07-01

Sandoz Pharmaceuticals

Head, Global Clinical Development & Medical Affairs, Biosimilars

2009-12-01 — 2011-06-01

Novartis

Vice President, Global Clinical Franchise Head, Immunology and Infectious Diseases

2009-01-01 — 2009-11-01

Novartis

Vice President, Sr. Global Program Medical Director, Neuroscience (Multiple Sclerosis)

2004-01-01 — 2008-12-01

Novartis

Vice President, Head of Global Medical Affairs, Transplantation and Immunology

2002-01-01 — 2004-01-01

Novartis

Executive Director and Head of US Medical Affairs, Transplantation and Immunology

2000-01-01 — 2002-01-01

Novartis

Director, US Medical Affairs, Transplantation and Immunology

1999-01-01 — 2000-01-01

University of Pennsylvania School of Medicine

Assistant Professor of Medicine, Transplant Nephrology

1995-01-01 — 1998-01-01

Skills

cardiovascular immunology neuroscience solid tumors hematology chemistry xrna radioligand gene & cell therapy

Languages

English , Spanish , Portuguese